Compare SSEA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSEA | TLPH |
|---|---|---|
| Founded | 2024 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.3M | 64.7M |
| IPO Year | 2025 | 2011 |
| Metric | SSEA | TLPH |
|---|---|---|
| Price | $10.03 | $1.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 63.2K | ★ 366.5K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $28,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $14,267.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.93 | $0.38 |
| 52 Week High | $10.03 | $1.57 |
| Indicator | SSEA | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 49.91 |
| Support Level | N/A | $1.20 |
| Resistance Level | N/A | $1.33 |
| Average True Range (ATR) | 0.00 | 0.12 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 16.03 |
Starry Sea Acquisition Corp is a newly organized blank check company.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.